ANDA 40733, held by Rising. Dipyridamole.
As of Nov 16, 2026, ANDA 40733 (Dipyridamole), held by Rising, was first approved by FDA on Feb 13, 2007, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 13, 2007 | Original application | Approved | None posted |
| Dipyridamole25MG · tablet;oral | Dipyridamole | Rx |
| Dipyridamole50MG · tablet;oral | Dipyridamole | Rx |
| Dipyridamole75MG · tablet;oral | Dipyridamole | Rx |
| Feb 2, 2021 | Supplement 6Labeling · Standard review | Approved | None posted |
| Nov 30, 2016 | Supplement 4Manufacturing | Approved | None posted |
| Feb 13, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters